Regulation of coronary vasomotor tone under normal conditions and during acute myocardial hypoperfusion

Pharmacology and Therapeutics

Volumn 86, Issue 1, 2000, Pages 87-110

  Duncker, Dirk J ^a   Bache, Robert J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Blood flow; Exercise; Ischemia; Microcirculation; Resistance vessels; Stenosis

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR; AMINOPHYLLINE; ANGIOTENSIN; AUTACOID; BETA ADRENERGIC RECEPTOR; BRADYKININ; CORONARY VASODILATING AGENT; ENDOTHELIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLIBENCLAMIDE; HISTAMINE; IBUPROFEN; ICATIBANT; IDAZOXAN; ISOSORBIDE; NIFEDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PHENOXYBENZAMINE; PHENTOLAMINE; PINACIDIL; POTASSIUM CHANNEL; PRAZOSIN; PROPRANOLOL; PROSTANOID; SEROTONIN; UNINDEXED DRUG; YOHIMBINE;

ARTERIOLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY VASCULAR RESISTANCE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ARTERIOLES; CORONARY VESSELS; HEART; HUMANS; MICROCIRCULATION; MYOCARDIAL ISCHEMIA; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION; VASOMOTOR SYSTEM;

EID: 0034019542     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(99)00074-1     Document Type: Review

References (210)

1. Afonso S., Bandow G.T., Rowe G.G. Indomethacin and the prostaglandin hypothesis of coronary blood flow regulation. J Physiol (Lond). 241:1974;299-308.
2. Alexander R.W., Kent K.M., Pisano J.J., Keiser H.R., Cooper T. Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J Clin Invest. 55:1975;1174-1181.
3. Altman J.D., Kinn J., Duncker D.J., Bache R.J. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovasc Res. 28:1994;119-124.
4. Amezcua J.L., Palmer R.M., de Souza B.M., Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol. 97:1989;1119-1124.
5. Aversano T., Becker L.C. Persistence of coronary vasodilator reserve despite functionally significant flow reduction. Am J Physiol. 248:1985;H403-H411.
6. Aversano T., Ouyang P., Silverman H. Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res. 69:1991;618-622.
7. Bacchus A.N., Ely S.W., Knabb R.M., Rubio R., Berne R.M. Adenosine and coronary blood flow in conscious dogs during normal physiological stimuli. Am J Physiol. 243:1982;H628-H633.
8. 2 mimetic U46619 worsens canine myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Cardiovasc Res. 26:1992;351-356.
9. Bache, R. J., & Duncker, D. J. (1994). Coronary steal. ACC Curr J Rev March/April, 9-12.
10. Bache R.J., Dai X.Z., Herzog C.A., Schwartz J.S. Effects of nonselective and selective alpha 1-adrenergic blockade on coronary blood flow during exercise. Circ Res. 61:1987;II36-II41.
11. Bache R.J., Dai X.Z., Schwartz J.S., Homans D.C. Role of adenosine in coronary vasodilation during exercise. Circ Res. 62:1988;846-853. a.
12. 1-adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise. J Pharmacol Exp Ther. 245:1988;232-237. b.
13. Bache R.J., Stark R.P., Duncker D.J. Serotonin selectively aggravates subendocardial ischemia distal to a coronary artery stenosis during exercise. Circulation. 86:1992;1559-1565.
14. Bardenheuer H., Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol. 250:1986;H173-H180.
15. Bassenge E., Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis. 30:1988;349-380.
16. Bassenge E., Kucharczyk M., Holtz J., Stoian D. Treadmill exercise in dogs under β-adrenergic blockade. adaptation of coronary and systemic hemodynamics Pflügers Arch. 332:1972;40-55.
17. Baumgarten C.R., Linz W., Kunkel G., Scholkens B.A., Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 108:1993;293-295.
18. Baydoun A.R., Woodward B. Effects of bradykinin in the rat isolated perfused heart. role of kinin receptors and endothelium-derived relaxing factor Br J Pharmacol. 103:1991;1829-1833.
19. Berne R.M., Rubio R. Regulation of coronary blood flow. Adv Cardiol. 12:1974;303-317.
20. Bernstein R.D., Ochoa F.Y., Xu X., Forfia P., Shen W., Thompson C.I., Hintze T.H. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 79:1996;840-848.
21. Beyer M.E., Slesak G., Nerz S., Kazmaier S., Hoffmeister H.M. Effects of endothelin-1 and IRL 1620 on myocardial contractility and myocardial energy metabolism. J Cardiovasc Pharmacol. 26:1995;S150-S152.
22. Boucek, R. J., Morales, A. R., Romanelli, R., & Judkins, M. P. (1983). Coronary artery branch arteries and collateral circulation: the vascular supply to specialized areas of the heart. In Coronary Artery Disease: Pathological and Clinical Assessment (pp. 1296-1305). Baltimore: Williams & Wilkins.
23. Bove A.A., Dewey J.D. Effects of serotonin and histamine on proximal and distal coronary vasculature in dogs. comparison with alpha-adrenergic stimulation Am J Cardiol. 52:1983;1333-1339.
24. Brazenor R.M., Angus J.A. Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol. 81:1982;569-576.
25. Brown I.P., Thompson C.I., Belloni F.L. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart. Am J Physiol. 264:1993;H821-H829.
26. Burke S.E., Lefer A.M., Nicolaou K.C., Smith G.M., Smith J.B. Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues. Br J Pharmacol. 78:1983;287-292.
27. Busse R., Lamontagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol. 344:1991;126-129.
28. Canty J.M. Jr., Klocke F.J. Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation. 71:1985;370-377.
29. Canty J.M. Jr., Smith T.P. Jr. Adenosine-recruitable flow reserve is absent during myocardial ischemia in unanesthetized dogs studied in the basal state. Circ Res. 76:1995;1079-1087.
30. 2-adrenergic receptors in the coronary microcirculation. Circulation. 84:1991;2108-2122. a.
31. Chilian W.M. Microvascular pressures and resistances in the left ventricular subepicardium and subendocardium. Circ Res. 69:1991;561-570. b.
32. Chilian W.M., Layne S.M. Coronary microvascular responses to reductions in perfusion pressure. Evidence for persistent arteriolar vasomotor tone during coronary hypoperfusion. Circ Res. 66:1990;1227-1238.
33. Chilian W.M., Boatwright R.B., Shoji T., Griggs D.M. Jr. Evidence against significant resting sympathetic coronary vasoconstrictor tone in the conscious dog. Circ Res. 49:1981;866-876.
34. Chilian W.M., Eastham C.L., Marcus M.L. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol. 251:1986;H779-H788.
35. Chilian W.M., Layne S.M., Eastham C.L., Marcus M.L. Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circ Res. 64:1989;376-388. a.
36. Chilian W.M., Layne S.M., Klausner E.C., Eastham C.L., Marcus M.L. Redistribution of coronary microvascular resistance produced by dipyridamole. Am J Physiol. 256:1989;H383-H390. b.
37. Clozel J.P., Clozel M. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res. 65:1989;1193-1200.
38. Clozel J.P., Sprecher U. Influence of low perfusion pressure on effect of endothelin on coronary vascular bed. Am J Physiol. 260:1991;H893-H901.
39. Cocks T.M., Angus J.A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 305:1983;627-630.
40. Cohen R.A. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade. J Pharmacol Exp Ther. 237:1986;548-552.
41. Cohen R.A., Shepherd J.T., Vanhoutte P.M. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am J Physiol. 245:1983;H1077-H1080.
42. Dai X.Z., Bache R.J. Effect of indomethacin on coronary blood flow during graded treadmill exercise in the dog. Am J Physiol. 247:1984;H452-H458.
43. 1-adrenergic blockade with indoramin. J Cardiovasc Pharmacol. 8:1986;574-581.
44. 2-adrenergic blockade. Am J Physiol. 256:1989;H1148-H1155.
45. Daut J., Maier-Rudolph W., von Beckerath N., Mehrke G., Gunther K., Goedel-Meinen L. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science. 247:1990;1341-1344.
46. Deussen A., Borst M., Kroll K., Schrader J. Formation of S-adenosylhomocysteine in the heart. II. a sensitive index for regional myocardial underperfusion Circ Res. 63:1988;250-261.
47. 2-adrenergic receptors on coronary resistance during exercise. J Appl Physiol. 64:1988;2287-2293.
48. Duling B.R., Berne R.M. Longitudinal gradients in periarteriolar oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow. Circ Res. 27:1970;669-678.
49. Duncker D.J., Bache R.J. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res. 74:1994;629-640.
50. Duncker D.J., Laxson D.D., Lindstrom P., Bache R.J. Endogenous adenosine and coronary vasoconstriction in hypoperfused myocardium during exercise. Cardiovasc Res. 27:1993;1592-1597. a.
51. ATP channels in coronary vasodilation during exercise. Circulation. 88:1993;1245-1253. b.
52. Duncker D.J., Mizrahi J., Bache R.J. Nitrovasodilators ITF 296 and isosorbide dinitrate exert antiischemic activity by dilating coronary penetrating arteries. J Cardiovasc Pharmacol. 25:1995;823-832. a.
53. ATP channel blockade. J Clin Invest. 95:1995;285-295. b.
54. 1-Adrenergic tone does not influence the transmural distribution of myocardial blood flow during exercise in dogs with pressure overload left ventricular hypertrophy. Basic Res Cardiol. 90:1995;73-83. c.
55. ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest. 97:1996;996-1009.
56. 2 consumption in awake swine at rest and during treadmill exercise. Circulation 96, I-73.
57. Duncker D.J., Ishibashi Y., Bache R.J. Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle. Am J Physiol. 275:1998;H1274-H1282. a.
58. ATP channels exert a vasodilator influence on the systemic and coronary circulation at rest and during treadmill exercise. Circulation 17, I-332.
59. Duncker D.J., Stubenitsky R., Verdouw P.D. Autonomic control of vasomotion in the porcine coronary circulation during treadmill exercise. evidence for feed-forward beta-adrenergic control Circ Res. 82:1998;1312-1322. c.
60. Duncker D.J., Stubenitsky R., Verdouw P.D. Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol. 275:1998;H1663-H1672. d.
61. Edlund A., Sollevi A. Theophylline increases coronary vascular tone in humans. evidence for a role of endogenous adenosine in flow regulation Acta Physiol Scand. 155:1995;303-311.
62. Edlund A., Sollevi A., Wennmalm A. The role of adenosine and prostacyclin in coronary flow regulation in healthy man. Acta Physiol Scand. 135:1989;39-46.
63. Edlund A., Conradsson T., Sollevi A. A role for adenosine in coronary vasoregulation in man. Effects of theophylline and enprofylline. Clin Physiol. 15:1995;623-636.
64. Egashira K., Katsuda Y., Mohri M., Kuga T., Tagawa T., Kubota T., Hirakawa Y., Takeshita A. Role of endothelium-derived nitric oxide in coronary vasodilatation induced by pacing tachycardia in humans. Circ Res. 79:1996;331-335.
65. Ekstrom-Jodal B., Haggendal E., Malmberg R., Svedmyr N. The effect of adrenergic β-receptor blockade on coronary circulation in man during work. Acta Med Scand. 191:1972;245-248.
66. Ely S.W., Knabb R.M., Bacchus A.N., Rubio R., Berne R.M. Measurements of coronary plasma and pericardial infusate adenosine concentrations during exercise in conscious dog. relationship to myocardial oxygen consumption and coronary blood flow J Mol Cell Cardiol. 15:1983;673-683.
67. Engler R.L. Adenosine an autocoid. Fozzard H.A., Haber E., Katz A.M., Morgan H.E. Scientific Foundations. 1991;1745-1765 Raven Press, New York.
68. Estes E.H. Jr., Entman M.L., Dixon H.B.D., Hackel D.B. The vascular supply of the left ventricular wall. Anatomic observations, plus a hypothesis regarding acute events in coronary artery disease. Am Heart J. 71:1966;58-67.
69. Feigl E.O. The paradox of adrenergic coronary vasoconstriction. Circulation. 76:1987;737-745.
70. Flameng W., Wusten B., Schaper W. On the distribution of myocardial flow. Part II. effects of arterial stenosis and vasodilation Basic Res Cardiol. 69:1974;435-446.
71. Flavahan N.A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 85:1992;1927-1938.
72. Folta A., Joshua I.G., Webb R.C. Dilator actions of endothelin in coronary resistance vessels and the abdominal aorta of the guinea pig. Life Sci. 45:1989;2627-2635.
73. Forman M.B., Oates J.A., Robertson D., Robertson R.M., Roberts L.J. II, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med. 313:1985;1138-1141.
74. Fujita M., Yamanishi K., Miwa K., Inoko M. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina. Coron Artery Dis. 5:1994;525-529.
75. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
76. Gaglione A., Hess O.M., Corin W.J., Ritter M., Grimm J., Krayenbuehl H.P. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease. J Am Coll Cardiol. 10:1987;299-310.
77. Gallagher K.P., Folts J.D., Shebuski R.J., Rankin J.H., Rowe G.G. Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogs. Am J Cardiol. 46:1980;67-73.
78. Gewirtz H., Williams D.O., Ohley W.H., Most A.S. Influence of coronary vasodilation on the transmural distribution of myocardial blood flow distal to a severe fixed coronary artery stenosis. Am Heart J. 106:1983;674-680.
79. Gewirtz H., Olsson R.A., Brautigan D.L., Brown P.R., Most A.S. Adenosine's role in regulating basal coronary arteriolar tone. Am J Physiol. 250:1986;H1030-H1036.
80. Gewirtz H., Olsson R.A., Most A.S. Role of adenosine in mediating the coronary vasodilative response to acute hypoxia. Cardiovasc Res. 21:1987;81-89.
81. Giles R.W., Wilcken D.E. Reactive hyperaemia in the dog heart. inter-relations between adenosine, ATP, and aminophylline and the effect of indomethacin Cardiovasc Res. 11:1977;113-121.
82. Ginsburg R., Bristow M.R., Kantrowitz N., Baim D.S., Harrison D.C. Histamine provocation of clinical coronary artery spasm. implications concerning pathogenesis of variant angina pectoris Am Heart J. 102:1981;819-822.
83. Gorman M.W., Sparks H.V. Jr. Progressive coronary vasoconstriction during relative ischemia in canine myocardium. Circ Res. 51:1982;411-420.
84. Gotoh K., Minamino T., Katoh O., Hamano Y., Fukui S., Hori M., Kusuoka H., Mishima M., Inoue M., Kamada T. The role of intracoronary thrombus in unstable angina. angiographic assessment and thrombolytic therapy during ongoing anginal attacks Circulation. 77:1988;526-534.
85. Grattan M.T., Hanley F.L., Stevens M.B., Hoffman J.I. Transmural coronary flow reserve patterns in dogs. Am J Physiol. 250:1986;H276-H283.
86. Groves P., Kurz S., Just H., Drexler H. Role of endogenous bradykinin in human coronary vasomotor control. Circulation. 92:1995;3424-3430.
87. Guth B.D., Heusch G., Seitelberger R., Ross J. Jr. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res. 60:1987;738-746.
88. 1-adrenergic blockade reduces exercise-induced regional myocardial ischemia in dogs. Basic Res Cardiol. 88:1993;282-296.
89. Gwirtz P.A., Stone H.L. Coronary blood flow and myocardial oxygen consumption after alpha adrenergic blockade during submaximal exercise. J Pharmacol Exp Ther. 217:1981;92-98.
90. Gwirtz P.A., Stone H.L. Coronary vascular response to adrenergic stimulation in exercise-conditioned dogs. Exerc Physiol. 57:1984;315-320.
91. 1-adrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol. 250:1986;H1117-H1126.
92. Hall J.L., Van Wylen D.G., Pizzurro R.D., Hamilton C.D., Reiling C.M., Stanley W.C. Myocardial interstitial purine metabolites and lactate with increased work in swine. Cardiovasc Res. 30:1995;351-356.
93. Hamm C.W., Lorenz R.L., Bleifeld W., Kupper W., Wober W., Weber P.C. Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol. 10:1987;998-1006.
94. Hanley F.L., Grattan M.T., Stevens M.B., Hoffman J.I. Role of adenosine in coronary autoregulation. Am J Physiol. 250:1986;H558-H566.
95. Hasdai D., Kornowski R., Battler A. Endothelin and myocardial ischemia. Cardiovasc Drugs Ther. 8:1994;589-599.
96. Heusch G., Deussen A. The effects of cardiac sympathetic nerve stimulation on perfusion of stenotic coronary arteries in the dog. Circ Res. 53:1983;8-15.
97. Heusch G., Guth B.D., Seitelberger R., Ross J. Jr. Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circulation. 75:1987;482-490.
98. Heyndrickx G.R., Pannier J.L., Muylaert P., Mabilde C., Leusen I. Alteration in myocardial oxygen balance during exercise after beta-adrenergic blockade in dogs. J Appl Physiol. 49:1980;28-33.
99. Heyndrickx G.R., Muylaert P., Pannier J.L. Alpha-adrenergic control of oxygen delivery to myocardium during exercise in conscious dogs. Am J Physiol. 242:1982;H805-H809.
100. 2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs. Circ Res. 54:1984;683-693.
101. Hintze T.H., Kaley G. Prostaglandins and the control of blood flow in the canine myocardium. Circ Res. 40:1977;313-320.
102. Hirsh P.D., Hillis L.D., Campbell W.B., Firth B.G., Willerson J.T. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 304:1981;685-691.
103. Hoffman J.I. Determinants and prediction of transmural myocardial perfusion. Circulation. 58:1978;381-391.
104. Hoffman J.I. Transmural myocardial perfusion. Prog Cardiovasc Dis. 29:1987;429-464.
105. Holtz J., Giesler M., Bassenge E. Two dilatory mechanisms of anti-anginal drugs on epicardial coronary arteries in vivo. indirect, flow-dependent, endothelium-mediated dilation and direct smooth muscle relaxation Z Kardiol. 72:1983;98-106.
106. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev. 46:1994;157-203.
107. Huang A.H., Feigl E.O. Adrenergic coronary vasoconstriction helps maintain uniform transmural blood flow distribution during exercise. Circ Res. 62:1988;286-298.
108. Ichikawa Y., Yokoyama M., Akita H., Fukuzaki H. Constriction of a large coronary artery contributes to serotonin-induced myocardial ischemia in the dog with pliable coronary stenosis. J Am Coll Cardiol. 14:1989;449-459.
109. Imamura Y., Tomoike H., Narishige T., Takahashi T., Kasuya H., Takeshita A. Glibenclamide decreases basal coronary blood flow in anesthetized dogs. Am J Physiol. 263:1992;H399-H404.
110. 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. Circ Res. 80:1997;196-207. a.
111. Ishibashi Y., Mizrahi J., Duncker D.J., Bache R.J. The nitric oxide donor ITF 1129 augments subendocardial blood flow during exercise-induced myocardial ischemia. J Cardiovasc Pharmacol. 30:1997;374-382. b.
112. + channels, adenosine, and nitric oxide-mediated mechanisms account for coronary vasodilation during exercise. Circ Res. 82:1998;346-359.
113. Ishizaka H., Okumura K., Yamabe H., Tsuchiya T., Yasue H. Endothelium-derived nitric oxide as a mediator of acetylcholine-induced coronary vasodilation in dogs. J Cardiovasc Pharmacol. 18:1991;665-669.
114. 2-adrenergic constriction in the canine epicardial coronary microcirculation. Circulation. 87:1993;1264-1274.
115. Jones C.J., Kuo L., Davis M.J., Chilian W.M. Regulation of coronary blood flow. coordination of heterogeneous control mechanisms in vascular microdomains Cardiovasc Res. 29:1995;585-596. a.
116. Jones C.J., Kuo L., Davis M.J., Chilian W.M. α-Adrenergic responses of isolated canine coronary microvessels. Basic Res Cardiol. 90:1995;61-69. b.
117. Jones C.J., Kuo L., Davis M.J., DeFily D.V., Chilian W.M. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation. 91:1995;1807-1813. c.
118. Jorgensen C.R., Wang K., Wang Y., Gobel F.L., Nelson R.R., Taylor H. Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise. Circulation. 48:1973;1173-1182.
119. Kadokami T., Egashira K., Kuwata K., Fukumoto Y., Kozai T., Yasutake H., Kuga T., Shimokawa H., Sueishi K., Takeshita A. Altered serotonin receptor subtypes mediate coronary microvascular hyperreactivity in pigs with chronic inhibition of nitric oxide synthesis. Circulation. 94:1996;182-189.
120. Kanatsuka H., Lamping K.G., Eastham C.L., Dellsperger K.C., Marcus M.L. Comparison of the effects of increased myocardial oxygen consumption and adenosine on the coronary microvascular resistance. Circ Res. 65:1989;1296-1305.
121. Kanatsuka H., Lamping K.G., Eastham C.L., Marcus M.L. Heterogeneous changes in epimyocardial microvascular size during graded coronary stenosis. Evidence of the microvascular site for autoregulation. Circ Res. 66:1990;389-396.
122. Kern M.J. Histaminergic modulation of coronary vascular resistance. are we missing a therapeutic adjunct for the treatment of myocardial ischemia? J Am Coll Cardiol. 17:1991;346-347.
123. Khouri E.M., Gregg D.E., Lowensohn H.S. Flow in the major branches of the left coronary artery during experimental coronary insufficiency in the unanesthetized dog. Circ Res. 23:1968;99-109.
124. Kirkeboen K.A., Naess P.A., Offstad J., Ilebekk A. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am J Physiol. 266:1994;H1516-H1527.
125. Kitakaze M., Minamino T., Node K., Komamura K., Shinozaki Y., Mori H., Kosaka H., Inoue M., Hori M., Kamada T. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs. Circulation. 92:1995;950-961.
126. Komaru T., Lamping K.G., Eastham C.L., Dellsperger K.C. Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res. 69:1991;1146-1151. a.
127. Komaru T., Lamping K.G., Eastham C.L., Harrison D.G., Marcus M.L., Dellsperger K.C. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs. Am J Physiol. 261:1991;H2001-H2007. b.
128. Kroll K., Feigl E.O. Adenosine is unimportant in controlling coronary blood flow in unstressed dog hearts. Am J Physiol. 249:1985;H1176-H1187.
129. Kuo L., Chilian W.M., Davis M.J. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am J Physiol. 261:1991;H1706-H1715.
130. G-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart. Pflügers Arch. 418:1991;266-270.
131. Lamontagne D., Konig A., Bassenge E., Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol. 20:1992;652-657.
132. Lamping K.G., Dole W.P. Flow-mediated dilation attenuates constriction of large coronary arteries to serotonin. Am J Physiol. 255:1988;H1317-H1324.
133. Lamping K.G., Marcus M.L., Dole W.P. Removal of the endothelium potentiates canine large coronary artery constrictor responses to 5-hydroxytryptamine in vivo. Circ Res. 57:1985;46-54.
134. Lamping K.G., Kanatsuka H., Eastham C.L., Chilian W.M., Marcus M.L. Nonuniform vasomotor responses of the coronary microcirculation to serotonin and vasopressin. Circ Res. 65:1989;343-351.
135. Langer S.Z. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol. 60:1977;481-497.
136. Larkin S.W., Clarke J.G., Keogh B.E., Araujo L., Rhodes C., Davies G.J., Taylor K.M., Maseri A. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol. 64:1989;956-958.
137. 2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res. 65:1989;1688-1697.
138. Laxson D.D., Dai X.Z., Homans D.C., Bache R.J. Coronary vasodilator reserve in ischemic myocardium of the exercising dog. Circulation. 85:1992;313-322.
139. Laxson D.D., Homans D.C., Bache R.J. Inhibition of adenosine-mediated coronary vasodilation exacerbates myocardial ischemia during exercise. Am J Physiol. 265:1993;H1471-H1477.
140. Lee S.C., Mallet R.T., Shizukuda Y., Williams A.G. Jr., Downey H.F. Canine coronary vasodepressor responses to hypoxia are attenuated but not abolished by 8-phenyltheophylline. Am J Physiol. 262:1992;H955-H960.
141. Lefroy D.C., Crake T., Uren N.G., Davies G.J., Maseri A. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation. 88:1993;43-54.
142. Liang I.Y., Stone H.L. Changes in diastolic coronary resistance during submaximal exercise in conditioned dogs. J Appl Physiol. 54:1983;1057-1062.
143. Linder L., Kiowski W., Buhler F.R., Luscher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation. 81:1990;1762-1767.
144. Marcus M.L., Chilian W.M., Kanatsuka H., Dellsperger K.C., Eastham C.L., Lamping K.G. Understanding the coronary circulation through studies at the microvascular level. Circulation. 82:1990;1-7.
145. Mass H., Gwirtz P.A. Myocardial flow and function after regional beta-blockade in exercising dogs. Med Sci Sports Exerc. 19:1987;443-450.
146. McKenzie J.E., Steffen R.P., Haddy F.J. Relationships between adenosine and coronary resistance in conscious exercising dogs. Am J Physiol. 242:1982;H24-H29.
147. McKenzie J.E., Steffen R.P., Haddy F.J. Effect of theophylline on adenosine production in the canine myocardium. Am J Physiol. 252:1987;H204-H210.
148. Merrill G.F., Haddy F.J., Dabney J.M. Adenosine, theophylline, and perfusate pH in the isolated, perfused guinea pig heart. Circ Res. 42:1978;225-229.
149. Merrill G.F., Downey H.F., Jones C.E. Adenosine deaminase attenuates canine coronary vasodilation during systemic hypoxia. Am J Physiol. 250:1986;H579-H583.
150. Mohrman D.E., Feigl E.O. Competition between sympathetic vasoconstriction and metabolic vasodilation in the canine coronary circulation. Circ Res. 42:1978;79-86.
151. Murray P.A., Vatner S.F. α-Adrenoceptor attenuation of the coronary vascular response to severe exercise in the conscious dog. Circ Res. 45:1979;654-660.
152. Myers P.R., Banitt P.F., Guerra R. Jr., Harrison D.G. Characteristics of canine coronary resistance arteries. importance of endothelium Am J Physiol. 257:1989;H603-H610.
153. Myers P.R., Katwa L.C., Tanner M., Morrow C., Guarda E., Parker J.L. Effects of angiotensin II on canine and porcine coronary epicardial and resistance arteries. J Vasc Res. 31:1994;338-346.
154. + channel blocker, inhibits coronary autoregulation in anesthetized dogs. Circ Res. 73:1993;771-776.
155. + channels regulates coronary blood flow in ischemic myocardium. Circulation. 95:1997;1560-1567.
156. 1 receptor stimulation on coronary artery diameter in patients with variant angina. comparison with effect of acetylcholine J Am Coll Cardiol. 17:1991;338-345.
157. Owen T.L., Ehrhart I.C., Weidner W.J., Scott J.B., Haddy F.J. Effects of indomethacin on local blood flow regulation in canine heart and kidney. Proc Soc Exp Biol Med. 149:1975;871-876.
158. Oza N.B., Schwartz J.H., Goud H.D., Levinsky N.G. Rat aortic smooth muscle cells in culture express kallikrein, kininogen, and bradykininase activity. J Clin Invest. 85:1990;597-600.
159. Pantely G.A., Bristow J.D., Swenson L.J., Ladley H.D., Johnson W.B., Anselone C.G. Incomplete coronary vasodilation during myocardial ischemia in swine. Am J Physiol. 249:1985;H638-H647.
160. Panza J.A., Quyyumi A.A., Brush J.E. Jr., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
161. Parent R., Pare R., Lavallee M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am J Physiol. 262:1992;H10-H16.
162. Park K.H., Rubin L.E., Gross S.S., Levi R. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res. 71:1992;992-1001.
163. Pohl U. Endothelial cells as part of a vascular oxygen-sensing system. hypoxia-induced release of autacoids Experientia. 46:1990;1175-1179.
164. Pohl U., Busse R. Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol. 256:1989;H1595-H1600.
165. Pupita G., Maseri A., Kaski J.C., Galassi A.R., Gavrielides S., Davies G., Crea F. Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med. 323:1990;514-520.
166. Quayle J.M., Nelson M.T., Standen N.B. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 77:1997;1165-1232.
167. Quilley J., Fulton D., McGiff J.C. Hyperpolarizing factors. Biochem Pharmacol. 54:1997;1059-1070.
168. Quyyumi A.A., Dakak N., Andrews N.P., Husain S., Arora S., Gilligan D.M., Panza J.A., Cannon R.O. III. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest. 95:1995;1747-1755.
169. Rafflenbeul W., Lichtlen P.R. Quantitative coronary angiography. evidence of a sustained increase in vascular smooth muscle tone in coronary artery stenoses Z Kardiol. 72:1983;87-91.
170. Richard V., Berdeaux A., la Rochelle C.D., Giudicelli J.F. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs. Br J Pharmacol. 104:1991;59-64.
171. Rossen J.D., Oskarsson H., Minor R.L. Jr., Talman C.L., Winniford M.D. Effect of adenosine antagonism on metabolically mediated coronary vasodilation in humans. J Am Coll Cardiol. 23:1994;1421-1426.
172. Ruocco N.A. Jr., Most A.S., Sasken H., Steiner M., Gewirtz H. Influence of serotonin on myocardial blood flow in the presence and absence of a coronary arterial stenosis. observations in domestic swine Proc Soc Exp Biol Med. 187:1988;416-424. a.
173. Ruocco N.A., Most A.S., Sasken H., Steiner M., Gewirtz H. Role of endogenous prostacyclin in myocardial blood flow regulation distal to a severe coronary stenosis. Cardiovasc Res. 22:1988;511-519. b.
174. Saino A., Pomidossi G., Perondi R., Valentini R., Rimini A., Di Francesco L., Mancia G. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation. 96:1997;148-153.
175. Saito D., Steinhart C.R., Nixon D.G., Olsson R.A. Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ Res. 49:1981;1262-1267.
176. Sakata Y., Komamura K., Hirayama A., Nanto S., Kitakaze M., Hori M., Kodama K. Elevation of the plasma histamine concentration in the coronary circulation in patients with variant angina. Am J Cardiol. 77:1996;1121-1126.
177. Samaha F.F., Heineman F.W., Ince C., Fleming J., Balaban R.S. ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol. 262:1992;C1220-C1227.
178. Sambuceti G., Marzilli M., Marraccini P., Schneider-Eicke J., Gliozheni E., Parodi O., L'Abbate A. Coronary vasoconstriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation. 95:1997;2652-2659.
179. Schrader J., Baumann G., Gerlach E. Adenosine as inhibitor of myocardial effects of catecholamines. Pflügers Arch. 372:1977;29-35.
180. Schutz W., Zimpfer M., Raberger G. Effect of aminophylline on coronary reactive hyperaemia following brief and long occlusion periods. Cardiovasc Res. 11:1977;507-511.
181. Schwartz J.S., Tockman B., Cohn J.N., Bache R.J. Exercise-induced decrease in flow through stenotic coronary arteries in the dog. Am J Cardiol. 50:1982;1409-1413.
182. 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res. 62:1988;436-442.
183. Sellke F.W., Myers P.R., Bates J.N., Harrison D.G. Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol. 258:1990;H515-H520.
184. Sherman C.T., Litvack F., Grundfest W., Lee M., Hickey A., Chaux A., Kass R., Blanche C., Matloff J., Morgenstern L., Gowz W., Swan H.J., Forrester J. Coronary angioscopy in patients with unstable angina pectoris. N Engl J Med. 315:1986;913-919.
185. Smith R.E., Palmer R.M., Bucknall C.A., Moncada S. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res. 26:1992;508-512.
186. Smith T.P. Jr., Canty J.M. Jr. Modulation of coronary autoregulatory responses by nitric oxide. Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res. 73:1993;232-240.
187. Sparks H.V. Jr., Bardenheuer H. Regulation of adenosine formation by the heart. Circ Res. 58:1986;193-201.
188. + channel modulation in arterial smooth muscle. Acta Physiol Scand. 164:1998;549-557.
189. + channels in arterial smooth muscle. Science. 245:1989;177-180.
190. Strader J.R., Gwirtz P.A., Jones C.E. Comparative effects of alpha-1 and alpha-2 adrenoceptors in modulation of coronary flow during exercise. J Pharmacol Exp Ther. 246:1988;772-778.
191. Symons J.D., Stebbins C.L. Effects of angiotensin II receptor blockade during exercise. comparison of losartan and saralasin J Cardiovasc Pharmacol. 28:1996;223-231.
192. Timmermans P.B., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.A., Smith R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 45:1993;205-251.
193. Traverse J.H., Judd D., Bache R.J. Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium. Circulation. 93:1996;558-566.
194. Tschudi M., Richard V., Buhler F.R., Luscher T.F. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol. 260:1991;H13-H20.
195. Ueeda M., Silvia S.K., Olsson R.A. Nitric oxide modulates coronary autoregulation in the guinea pig. Circ Res. 70:1992;1296-1303.
196. Van den Berg E.K., Schmitz J.M., Benedict C.R., Malloy C.R., Willerson J.T., Dehmer G.J. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation. 79:1989;116-124.
197. Vanhoutte P.M. Endothelial dysfunction and inhibition of converting enzyme. Eur Heart J. 19:1998;J7-J15.
198. 2 serotonergic receptors. J Pharmacol Exp Ther. 218:1981;217-230.
199. 2 receptors J Am Coll Cardiol. 10:1987;1207-1213.
200. Watkinson W.P., Foley D.H., Rubio R., Berne R.M. Myocardial adenosine formation with increased cardiac performance in the dog. Am J Physiol. 236:1979;H13-H21.
201. Wei H.M., Kang Y.H., Merrill G.F. Coronary vasodilation during global myocardial hypoxia. effects of adenosine deaminase Am J Physiol. 254:1988;H1004-H1009.
202. Wenzel R.R., Fleisch M., Shaw S., Noll G., Kaufmann U., Schmitt R., Jones C.R., Clozel M., Meier B., Luscher T.F. Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease. Circulation. 98:1998;2235-2240.
203. Wiest E., Trach V., Dammgen J. Removal of endothelial function in coronary resistance vessels by saponin. Basic Res Cardiol. 84:1989;469-478.
204. Winbury M.M., Howe B.B., Hefner M.A. Effect of nitrates and other coronary dilators on large and small coronary vessels. an hypothesis for the mechanism of action of nitrates J Pharmacol Exp Ther. 168:1969;70-95.
205. Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 40:1969;501-511.
206. Woodman O.L. Enhanced coronary vasoconstrictor responses to 5-hydroxytryptamine in the presence of a coronary artery stenosis in anaesthetized dogs. Br J Pharmacol. 100:1990;153-157.
207. Woodman O.L., Dusting G.J. N-Nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds. Br J Pharmacol. 103:1991;1407-1410.
208. Yada T., Richmond K.N., Van Bibber R., Kroll K., Feigl E.O. Role of adenosine in local metabolic coronary vasodilation. Am J Physiol. 276:1999;H1425-H1433.
209. Yamabe H., Okumura K., Ishizaka H., Tsuchiya T., Yasue H. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia. Am J Physiol. 263:1992;H8-H14.
210. Zeiher A.M., Krause T., Schachinger V., Minners J., Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 91:1995;2345-2352.